WallStSmart

Accenture plc (ACN)vsDXC Technology Co (DXC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Accenture plc generates 469% more annual revenue ($72.11B vs $12.68B). ACN leads profitability with a 10.6% profit margin vs 3.3%. DXC appears more attractively valued with a PEG of 0.49. DXC earns a higher WallStSmart Score of 67/100 (B-).

ACN

Buy

60

out of 100

Grade: C+

Growth: 4.7Profit: 7.0Value: 7.3Quality: 5.3
Piotroski: 3/9Altman Z: 2.79

DXC

Strong Buy

67

out of 100

Grade: B-

Growth: 4.7Profit: 5.5Value: 10.0Quality: 6.5
Piotroski: 6/9Altman Z: 1.13
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACNSignificantly Overvalued (-19.5%)

Margin of Safety

-19.5%

Fair Value

$160.91

Current Price

$192.29

$31.38 premium

UndervaluedFair: $160.91Overvalued
DXCUndervalued (+87.2%)

Margin of Safety

+87.2%

Fair Value

$107.64

Current Price

$12.01

$95.63 discount

UndervaluedFair: $107.64Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACN4 strengths · Avg: 8.5/10
Market CapQuality
$118.34B9/10

Large-cap with strong market position

Return on EquityProfitability
24.8%9/10

Every $100 of equity generates 25 in profit

P/E RatioValuation
15.8x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$3.67B8/10

Generating 3.7B in free cash flow

DXC4 strengths · Avg: 10.0/10
PEG RatioValuation
0.4910/10

Growing faster than its price suggests

P/E RatioValuation
5.2x10/10

Attractively priced relative to earnings

Price/BookValuation
0.6x10/10

Reasonable price relative to book value

EPS GrowthGrowth
96.8%10/10

Earnings expanding 96.8% YoY

Areas to Watch

ACN3 concerns · Avg: 3.7/10
PEG RatioValuation
1.554/10

Expensive relative to growth rate

EPS GrowthGrowth
4.0%4/10

4.0% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

DXC4 concerns · Avg: 2.5/10
Profit MarginProfitability
3.3%3/10

3.3% margin — thin

Debt/EquityHealth
1.523/10

Elevated debt levels

Revenue GrowthGrowth
-100.0%2/10

Revenue declined 100.0%

Altman Z-ScoreHealth
1.132/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ACN

The strongest argument for ACN centers on Market Cap, Return on Equity, P/E Ratio.

Bull Case : DXC

The strongest argument for DXC centers on PEG Ratio, P/E Ratio, Price/Book. PEG of 0.49 suggests the stock is reasonably priced for its growth.

Bear Case : ACN

The primary concerns for ACN are PEG Ratio, EPS Growth, Piotroski F-Score.

Bear Case : DXC

The primary concerns for DXC are Profit Margin, Debt/Equity, Revenue Growth. Debt-to-equity of 1.52 is elevated, increasing financial risk. Thin 3.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

ACN carries more volatility with a beta of 1.25 — expect wider price swings.

ACN is growing revenue faster at 8.3% — sustainability is the question.

ACN generates stronger free cash flow (3.7B), providing more financial flexibility.

Monitor INFORMATION TECHNOLOGY SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DXC scores higher overall (67/100 vs 60/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Accenture plc

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Accenture plc is an Irish-domiciled multinational company that provides consulting and processing services. It has been incorporated in Dublin, Ireland since 2009.

DXC Technology Co

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

DXC Technology is an American multinational corporation that provides business-to-business information technology services.

Visit Website →

Want to dig deeper into these stocks?